Ulmus davidiana Nakai induces apoptosis and autophagy on non-small cell lung cancer cells.

J Ethnopharmacol

Brain Korea 21 Program for Biomedicine Science, Korea University College of Medicine, Korea University, Seoul 136-705, Republic of Korea; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 152-703, Republic of Korea. Electronic address:

Published: April 2017

Ethnopharmacological Relevance: Ulmus davidiana Nakai (UDN) is frequently used in the treatment of cancer in traditional oriental medicine. Although several reports indicate that UDN has inhibitory effects in some cancers, there has been no report on the inhibitory effects of UDN via both autophagy and apoptosis.

Materials And Methods: Cytotoxicity induced by UDN in human non-small cell lung cancer (NSCLC) H-1299 and H-460 cell lines was evaluated using the 2, 3-Bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) assay and trypan blue exclusion assay. Induction of apoptosis was also investigated using Hoechst staining and annexin-V binding assay and was confirmed with western blot analysis. Induction of autophagy was investigated through observation of autophagy vacuoles under inverted phase-contrast microscopy and was confirmed by observing the formation of autophagy vacuoles under a fluorescence microscope using monodansylcadaverine (MDC) staining and western blot analysis. The in vivo anti-tumorigenic effect of UDN was investigated in an athymic nude mouse xenograft model using H-1299 NSCLC cells.

Results: UDN exhibited a marked inhibitory effect on cell growth in H-1299 and H-460 human NSCLC cell lines in a dose- and time-dependent manner in vitro and in vivo. It induced not only apoptosis, but also autophagy in both H-1299 and H-460 cells in a dose-dependent manner. UDN-mediated autophagy led to the accumulation of autophagosome, resulting in apoptosis induction and cell death.

Conclusions: From our current knowledge, we are the first to demonstrate that UDN has the potential to induce both autophagy and apoptosis in H-1299 and H-460 human NSCLC cell lines. We suggest that UDN can be considered a potential candidate for lung cancer-specific chemotherapy with efficacy as a cytotoxic agent.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2017.03.009DOI Listing

Publication Analysis

Top Keywords

h-1299 h-460
16
cell lines
12
ulmus davidiana
8
davidiana nakai
8
autophagy
8
apoptosis autophagy
8
non-small cell
8
cell lung
8
lung cancer
8
udn
8

Similar Publications

Ulmus davidiana Nakai induces apoptosis and autophagy on non-small cell lung cancer cells.

J Ethnopharmacol

April 2017

Brain Korea 21 Program for Biomedicine Science, Korea University College of Medicine, Korea University, Seoul 136-705, Republic of Korea; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 152-703, Republic of Korea. Electronic address:

Ethnopharmacological Relevance: Ulmus davidiana Nakai (UDN) is frequently used in the treatment of cancer in traditional oriental medicine. Although several reports indicate that UDN has inhibitory effects in some cancers, there has been no report on the inhibitory effects of UDN via both autophagy and apoptosis.

Materials And Methods: Cytotoxicity induced by UDN in human non-small cell lung cancer (NSCLC) H-1299 and H-460 cell lines was evaluated using the 2, 3-Bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) assay and trypan blue exclusion assay.

View Article and Find Full Text PDF

MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.

Oncogene

June 2006

Translational Oncology Unit CSIC/UAM, Instituto de Investigaciones Biomédicas, C/Arturo Duperier, Madrid, Spain.

Non-small-cell lung cancer (NSCLC) represents the most frequent and therapy-refractive sub-class of lung cancer. Improving apoptosis induction in NSCLC represents a logical way forward in treating this tumor. Cisplatin, a commonly used therapeutic agent in NSCLC, induces activation of N-terminal-c-Jun kinase (JNK) that, in turn, mediates induction of apoptosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!